AOBiome announces the publication of positive Ph 2b results
16 May 2023 //
PR NEWSWIRE
AOBiome Granted Composition of Matter Patent for its Clinical Candidate B244
06 Apr 2023 //
PR NEWSWIRE
AOBiome reports positive Phase IIb data of topical atopic dermatitis asset
22 Feb 2022 //
CLINICALTRIALSARENA
AOBiome Achieves Landmark Recruitment Goal in Largest Clinical Trial
16 Nov 2021 //
PRNEWSWIRE
AOBiome`s New Shelf-Stable Formulation Of Its AOB Shows Reduction Of Itch Levels
17 Aug 2021 //
PRNEWSWIRE